Jay Luly
Vorstandsvorsitzender bei ENANTA PHARMACEUTICALS, INC.
Vermögen: 10 Mio $ am 30.04.2024
Aktive Positionen von Jay Luly
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ENANTA PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 01.07.2003 | - |
| Vorstandsvorsitzender | 01.07.2003 | - | |
| Präsident | 01.07.2003 | - |
Karriereverlauf von Jay Luly
Ehemalige bekannte Positionen von Jay Luly
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ABBOTT LABORATORIES | Corporate Officer/Principal | 01.01.1983 | - |
LeukoSite, Inc.
 LeukoSite, Inc. Pharmaceuticals: MajorHealth Technology LeukoSite, Inc. develops drugs for treatment of cancer and inflammatory diseases. It produces drugs to block autoimmune and viral diseases associated with malfunctioning leukocytes or white blood cells. The company was founded in 1992 and is located in Cambridge, MA. | Corporate Officer/Principal | - | - |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
| Corporate Officer/Principal | - | - | |
| The Boston Biomedical Research Institute | Direktor/Vorstandsmitglied | 18.10.2010 | - |
Artesian Therapeutics, Inc.
 Artesian Therapeutics, Inc. BiotechnologyHealth Technology Artesian Therapeutics, Inc. develops and manufactures biopharmaceutical therapeutic products. Its products are used for the treatment of cardiovascular and other life threat diseases. The company was founded by Peter D. Suzdak in March 2002 and is located in Gaithersburg, MD | Direktor/Vorstandsmitglied | - | - |
Ausbildung von Jay Luly
| University of California, Berkeley | Doctorate Degree |
| University of Illinois | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 9 |
Operativ
| Director/Board Member | 3 |
| Corporate Officer/Principal | 3 |
| Chief Executive Officer | 1 |
Sektoral
| Health Technology | 6 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ABBOTT LABORATORIES | Health Technology |
| ENANTA PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
LeukoSite, Inc.
LeukoSite, Inc. Pharmaceuticals: MajorHealth Technology LeukoSite, Inc. develops drugs for treatment of cancer and inflammatory diseases. It produces drugs to block autoimmune and viral diseases associated with malfunctioning leukocytes or white blood cells. The company was founded in 1992 and is located in Cambridge, MA. | Health Technology |
Artesian Therapeutics, Inc.
Artesian Therapeutics, Inc. BiotechnologyHealth Technology Artesian Therapeutics, Inc. develops and manufactures biopharmaceutical therapeutic products. Its products are used for the treatment of cardiovascular and other life threat diseases. The company was founded by Peter D. Suzdak in March 2002 and is located in Gaithersburg, MD | Health Technology |
| The Boston Biomedical Research Institute |
